14 43

Cited 0 times in

Differences in Antimicrobial Resistance Phenotypes by the Group of CTX-M Extended-Spectrum β-Lactamase

Other Titles
 CTX-M 광범위 베타락탐 분해효소의 그룹별 내성표현형 차이 
Authors
 Bareum Gwon  ;  Eun-Jeong Yoon  ;  Dokyun Kim  ;  Hyukmin Lee  ;  Jong Hee Shin  ;  Jeong Hwan Shin  ;  Kyeong Seob Shin  ;  Young Ah Kim  ;  Young Uh  ;  Hyun Soo Kim  ;  Young Ree Kim  ;  Seok Hoon Jeong 
Citation
 Annals of Clinical Microbiology, Vol.22(1) : 1-8, 2019 
Journal Title
 Annals of Clinical Microbiology 
ISSN
 2288-0585 
Issue Date
2019
Keywords
CTX-M ; Escherichia coli ; Extended-spectrum β-lactamase ; Klebsiella pneumoniae
Abstract
Background : Escherichia coli and Klebsiella pneumoniae clinical isolates producing CTX-M extended-spectrum β-lactamases (ESBLs) were assessed for antimicrobial resistance phenotypes varied by group of enzymes. Methods : A total of 1,338 blood isolates, including 959 E. coli and 379 K. pneumoniae, were studied. All the strains were collected between January and July 2017 from eight general hospitals in South Korea. The species were identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Antimicrobial susceptibilities were determined by disk diffusion methods and ESBL phenotypes by double-disk synergy tests using disks containing cefotaxime, ceftazidime, cefepime, aztreonam, and clavulanic acid (CA). The genes for β-lactamases were identified by PCR and sequencing. Results : Of total microbes, 31.6% (303/959) E. coli and 24.0% (91/379) K. pneumoniae were resistant to cefotaxime and 28.1% (269/959) E. coli and 20.1% (76/379) K. pneumoniae were CTX-M-type ESBL producers. Among the detected CTX-M ESBLs, 58.0% (156/269) in E. coli and 86.8% (66/76) in K. pneumoniae belonged to group 1, 46.8% (126/269) in E. coli and 14.5% (11/76) in K. pneumoniae were group 9. Ten E. coli and one K. pneumoniae isolates co-produced both groups of CTX-M ESBL. The group 1 CTX-M producers had a higher level of resistance to cefotaxime, ceftazidime, cefepime, and aztreonam and exhibited stronger synergistic activities when combined with CA compared to group 9. Conclusion : ESBL phenotypes differ by CTX-M ESBL group and phenotype testing with drugs including 4th generation cephalosporins and monobactams is critical for screening CTX-M-producers with better sensitivity.
Files in This Item:
T201900933.pdf Download
DOI
10.5145/ACM.2019.22.1.1
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Laboratory Medicine (진단검사의학교실) > 1. Journal Papers
Yonsei Authors
Kim, Dokyun(김도균) ORCID logo https://orcid.org/0000-0002-0348-5440
Lee, Hyuk Min(이혁민) ORCID logo https://orcid.org/0000-0002-8523-4126
Jeong, Seok Hoon(정석훈) ORCID logo https://orcid.org/0000-0001-9290-897X
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/169366
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse